Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Copper deficiency results in increased expression of SLC31A1 mRNA; Copper deficiency results in increased expression of SLC31A1 protein; Copper results in increased expression of SLC31A1 mRNA; Copper results in increased expression of SLC31A1 protein
Copper inhibits the reaction [SLC31A1 protein results in increased import of oxaliplatin]; Fructose inhibits the reaction [Copper deficiency results in increased expression of SLC31A1 protein]; lead acetate promotes the reaction [SLC31A1 protein results in increased uptake of Copper]; PRL protein promotes the reaction [SLC31A1 protein results in increased secretion of Copper]; Silver inhibits the reaction [SLC31A1 protein results in increased import of Copper]; SLC31A1 mutant form inhibits the reaction [Lead results in decreased export of Copper]; Zinc inhibits the reaction [SLC31A1 protein results in increased import of Copper]
Copper deficiency results in increased expression of SLC31A1 mRNA; Copper deficiency results in increased expression of SLC31A1 protein; Copper results in increased expression of SLC31A1 protein
[bathocuproine sulfonate results in decreased abundance of Copper] which results in increased expression of SLC31A1 mRNA; [Buthionine Sulfoximine results in decreased abundance of Glutathione] inhibits the reaction [SLC31A1 protein results in increased import of Copper]; [CLDN3 protein results in increased expression of SLC31A1 protein] which results in increased import of and results in increased abundance of Copper; [CLDN4 protein results in increased expression of SLC31A1 protein] which results in increased import of and results in increased abundance of Copper; [Copper results in decreased expression of SLC31A1 mRNA] which results in decreased uptake of Copper; [ITGAV protein results in decreased expression of SLC31A1 protein] which results in decreased abundance of Copper; [Metribolone results in increased expression of SLC31A1 protein] which results in increased import of Copper; [NSC 689534 binds to Copper] which results in increased expression of SLC31A1 mRNA; [SLC11A2 protein co-treated with SLC31A1 protein] affects the uptake of Copper; Buthionine Sulfoximine inhibits the reaction [SLC31A1 protein results in increased import of Copper]; Chlorpromazine inhibits the reaction [Copper affects the localization of SLC31A1 protein]; Cisplatin inhibits the reaction [SLC31A1 protein results in increased import of Copper]; Copper deficiency promotes the reaction [SP1 protein results in increased expression of SLC31A1 mRNA]; Copper inhibits the reaction [SP1 protein results in increased expression of SLC31A1 mRNA]; Copper results in decreased expression of and affects the localization of SLC31A1 protein; Copper results in increased degradation of and affects the localization of SLC31A1 protein; Estradiol inhibits the reaction [Copper results in decreased expression of SLC31A1 protein]; Estradiol promotes the reaction [Copper affects the expression of SLC31A1 mRNA]; glutathione diethyl ester inhibits the reaction [Buthionine Sulfoximine inhibits the reaction [SLC31A1 protein results in increased import of Copper]]; methyl-beta-cyclodextrin inhibits the reaction [Copper affects the localization of SLC31A1 protein]; SLC31A1 protein results in increased susceptibility to [cupric chloride results in increased abundance of Copper]
[ATP7B gene mutant form results in decreased export of Copper] which results in decreased expression of SLC31A1 protein; [ATP7B gene mutant form results in increased uptake of Copper] which results in decreased expression of SLC31A1 protein; [Oxygen deficiency results in increased expression of SLC31A1 protein] which results in increased uptake of Copper; [SLC31A1 gene mutant form affects the abundance of Copper] which results in decreased activity of SOD1 protein; [SLC31A1 gene mutant form affects the abundance of Copper] which results in decreased activity of TYR protein; [SLC31A1 gene mutant form affects the abundance of Copper] which results in decreased expression of COX1 protein; [SLC31A1 gene mutant form results in increased abundance of CCS protein] which results in decreased abundance of Copper; [SLC31A2 protein results in increased expression of SLC31A1 protein modified form] which results in decreased abundance of Copper; Copper inhibits the reaction [[SLC31A1 gene mutant form affects the abundance of Copper] which results in decreased activity of SOD1 protein]; Copper inhibits the reaction [[SLC31A1 gene mutant form affects the abundance of Copper] which results in decreased activity of TYR protein]; Copper inhibits the reaction [[SLC31A1 gene mutant form affects the abundance of Copper] which results in decreased expression of COX1 protein]; SLC31A1 protein results in increased uptake of and results in increased abundance of Copper; SLC31A2 protein inhibits the reaction [SLC31A1 protein results in increased uptake of and results in increased abundance of Copper]
